Nordic Nanovector increases IPO deal size on high demand
Nordic Nanovector, the Norwegian biotech company, has increased the size of its initial public offering in Oslo to reflect strong investor demand for the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: